budesonide
FDA Approves First Oral Budesonide for EoE
The FDA approved the first oral suspension of budesonide (Eohilia, Takeda) for patients with eosinophilic ...
FEBRUARY 12, 2024
Expert Picks From ACG 2021: Luminal Diseases
In this month’s installment of “Expert Picks,” Brooks D. Cash, MD, discusses his favorite ...
MARCH 18, 2022
Pooled Analysis Supports Oral Budesonide for EoE, but FDA Says More Research Needed
An oral suspension, immediate-release form of budesonide is safer and more effective than placebo for children and ...
MARCH 13, 2022
First Drug for Treatment of EoE Getting Closer
The first drug with a specific indication for eosinophilic esophagitis appears to be nearing approval in the United ...
JUNE 8, 2020
Budesonide and Fluticasone Differ Little for EoE
San Diego—A slurry of budesonide is not better than inhaled fluticasone for controlling eosinophilic ...
AUGUST 26, 2019
Robust Benefit for Oral Budesonide In Lymphocytic Colitis
An oral regimen of once-daily budesonide was significantly more effective than mesalamine in inducing clinical and ...
SEPTEMBER 19, 2018
